Additionally, we observed that PGK1 was related to the prognosis of BLCA patients who received chemotherapeutic drugs (Figure 2E) but had no impact on the prognosis of patients who did not undergo chemotherapy (Figure 2F). The gene discussed is PGK1; the disease is bladder transitional cell carcinoma.